Literature DB >> 11799264

The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in hemodialysis patients: a prospective study.

A J Luik1, F M v d Sande, P Weideman, E Cheriex, J P Kooman, K M Leunissen.   

Abstract

A good blood pressure control can be achieved with long hemodialysis sessions (dialysis center of Tassin, France). However, it is not well known whether a higher dialysis dose or a lower dry weight is responsible for this phenomenon. In a preliminary study, 21 hypertensive dialysis patients, dialyzed three times a week for 3-5 h, were randomized into three groups during a 3-month study period. In 6 patients, the dialysis treatment time was increased by 2 h, and the dry weight was gradually decreased (group 1). In 7 patients the dialysis treatment time was increased by 2 h without a change in dry weight (group 2). In 8 patients the dry weight was gradually lowered without changing the dialysis treatment time (group 3). Before and after the study, cardiac index and left ventricular mass index (echocardiography) and forearm vascular resistance (strain gauge plethysmography) were determined on a middialytic day. The blood pressure was assessed by 48-hour ambulatory monitoring. The antihypertensive medication was reduced when the postdialytic blood pressure became <130/80 mm Hg. The dry weight was reduced by 2.6 +/- 1.4 kg in group 1 and by 2.3 +/- 0.8 kg in group 3 (p < 0.05). The number of classes of antihypertensive medication was reduced from 3.3 to 1.8 in group 1 (NS), from 2.4 to 1.7 in group 2 (NS), and from 3.1 to 1.3 in group 3 (p < 0.05). The dose of the remaining antihypertensive drugs was reduced by 50% in group 1 (p < 0.05), by 32% in group 2 (NS), and by 72.2% in group 3 (p < 0.05). The interdialytic systolic blood pressure decreased significantly after increasing the dialysis time without changing the dry weight (group 2: 7 +/- 5 mm Hg; p < 0.05). The systolic blood pressure was also lower in the other patients groups: group 1: 13 +/- 26 mm Hg, group 3 : 7 +/- 16 mm Hg (NS). The pulse pressure decreased significantly in group 2 (7 +/- 5 mm Hg; p < 0.05) and in group 3 (6 +/- 7 mm Hg; p < 0.05) and tended to decrease in group 1 (11 +/- 12 mm Hg; p = 0.08). The diastolic blood pressure and the day-night blood pressure difference did not change significantly, nor did cardiac index and left ventricular mass index. The forearm vascular resistance tended to decrease in the patients on long dialysis sessions. This preliminary study suggests that the dialysis treatment time might have an independent beneficial effect on blood pressure control. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11799264     DOI: 10.1159/000046651

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  8 in total

1.  Dialysis: Normovolemia is a therapeutic target for hypertension.

Authors:  Matthias P Hörl; Walter H Hörl
Journal:  Nat Rev Nephrol       Date:  2009-08       Impact factor: 28.314

Review 2.  Beyond Kt/V: redefining adequacy of dialysis in the 21st century.

Authors:  Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 3.  The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessions.

Authors:  Charles Chazot; Guillaume Jean
Journal:  Nat Clin Pract Nephrol       Date:  2008-11-25

4.  Predialysis hypotension is not a predictor for mortality in long-term hemodialysis patients: insight from a single-center observational study.

Authors:  Wen-Hung Huang; Ching-Wei Hsu; Ching-Chih Hu; Tzung-Hai Yen; Cheng-Hao Weng
Journal:  Ther Clin Risk Manag       Date:  2016-08-24       Impact factor: 2.423

5.  The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis.

Authors:  James Fotheringham; Ayesha Sajjad; Vianda S Stel; Keith McCullough; Angelo Karaboyas; Martin Wilkie; Brian Bieber; Bruce M Robinson; Ziad A Massy; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2019-09-01       Impact factor: 5.992

Review 6.  Hypertension in patients on dialysis: diagnosis, mechanisms, and management.

Authors:  Sérgio Gardano Elias Bucharles; Krissia K S Wallbach; Thyago Proença de Moraes; Roberto Pecoits-Filho
Journal:  J Bras Nefrol       Date:  2018-11-08

Review 7.  Role of Antihypertensives in End-Stage Renal Disease: A Systematic Review.

Authors:  Rizwan Rabbani; Edva Noel; Suzanne Boyle; Hema Balina; Sabahat Ali; Bolajoko Fayoda; Waqas Ahmad Khan
Journal:  Cureus       Date:  2022-07-20

8.  Short daily versus conventional hemodialysis for hypertensive patients: a randomized cross-over study.

Authors:  Deborah L Zimmerman; Marcel Ruzicka; Paul Hebert; Dean Fergusson; Rhian M Touyz; Kevin D Burns
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.